Clinical Trial Update: A Study of MG-K10 in Chronic Spontaneous Urticaria [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 clinical trial evaluating MG-K10 for chronic spontaneous urticaria, which is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• MG-K10

Snippet

Sponsor: Shanghai Mabgeek Biotech.Co.Ltd | Conditions: Chronic Spontaneous Urticaria (CSU) | Phase 3 | Status: NOT_YET_RECRUITING